MI Sign Up for eTOC Alerts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bayliss, D. A.
Right arrow Articles by Talley, E. M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Bayliss, D. A.
Right arrow Articles by Talley, E. M.
Molecular Interventions 3:252 (2003)
© 2003 American Society of Pharmacology and Experimental Therapeutics


erratum: The TASK Family: Two-Pore Domain Background K+ Channels

Douglas A. Bayliss, Jay E. Sirois and Edmund M. Talley

Mol. Interv. 3 , 205–219 (2003) Douglas A. Bayliss, Jay E. Sirois, and Edmund M. Talley. Figure 3 was inadvertently omitted from the review. Figure 3 has now been placed back into the review and the error has been corrected (see online version). We apologize to the authors and our readers for the error.





This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bayliss, D. A.
Right arrow Articles by Talley, E. M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Bayliss, D. A.
Right arrow Articles by Talley, E. M.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ASPET Journals Pharmacological Reviews Drug Metabolism and Disposition
Molecular Interventions Molecular Pharmacology J Pharmacology and Exp Therapeutics
Copyright © 2003 by the American Society for Pharmacology and Experimental Therapeutics.